McDavid Stilwell

McDavid Stilwell

former Chief Financial OfficeratCoherus Oncology· In proxies 2021–2023

Pay in FY2023+10% from the year before · Coherus Oncology stock -58.0% the same year

McDavid Stilwell was paid $2.3M in FY2023 (Dec), up 10%. Coherus Oncology stock fell 58.0% that year.

Pay$100 in the stock at the end of FY20 → $19
Pay is from the Summary Compensation Table of each Coherus Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Coherus OncologyPublic company · 5 yr
    • former Chief Financial Officer2021 – Present · 5 yrStock in role -93%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?